Alzheimer's drug sneaks through blood–brain barrier

A double-sided antibody targets enzyme to reduce levels of harmful amyloid-β protein in monkeys. Access through your institution Buy or subscribe This is a preview of subscription content,

access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn

more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS

OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Yu, Y. J. et al. _Sci. Transl. Med._ 6, 261ra154 (2014). Article  CAS 

Google Scholar  * Couch, J. A. et al. _Sci. Transl. Med._ 5, 183ra57 (2013). Article  CAS  Google Scholar  Download references Authors * Sara Reardon View author publications You can also

search for this author inPubMed Google Scholar ELECTRONIC SUPPLEMENTARY MATERIAL Two-sided antibody RELATED LINKS RELATED LINKS RELATED LINKS IN NATURE RESEARCH Small-molecule drug drives

cancer cells to suicide 2013-Feb-07 Nanomaterials offer hope for cerebral palsy 2012-Apr-18 Engineered antibodies cross blood–brain barrier 2011-May-25 Biotechnology: Crossing the barrier

2010-Aug-18 RELATED EXTERNAL LINKS Ryan Watts RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reardon, S. Alzheimer's drug sneaks through

blood–brain barrier. _Nature_ (2014). https://doi.org/10.1038/nature.2014.16291 Download citation * Published: 05 November 2014 * DOI: https://doi.org/10.1038/nature.2014.16291 SHARE THIS

ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative